Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4458031000168113 | isatuximab 100 mg / 5 mL injection, 5 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4458041000168116 | isatuximab 100 mg/5 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
isatuximab 100 mg/5 mL injection, vial | Is a | isatuximab | true | Inferred relationship | Some | ||
isatuximab 100 mg/5 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
isatuximab 100 mg/5 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
isatuximab 100 mg/5 mL injection, vial | has Australian BoSS | isatuximab | true | Inferred relationship | Some | 360346917 | |
isatuximab 100 mg/5 mL injection, vial | has intended active ingredient | isatuximab | true | Inferred relationship | Some | 360346917 | |
isatuximab 100 mg/5 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 86906670 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Sarclisa 100 mg/5 mL injection, 5 mL vial | Is a | True | isatuximab 100 mg/5 mL injection, vial | Inferred relationship | Some | |
isatuximab 100 mg/5 mL injection, 5 mL vial | has MPUU | True | isatuximab 100 mg/5 mL injection, vial | Inferred relationship | Some | 1761128995 |
isatuximab 100 mg/5 mL injection, 3 x 5 mL vials | has MPUU | True | isatuximab 100 mg/5 mL injection, vial | Inferred relationship | Some | 1875203970 |
Reference Sets
Medicinal product unit of use reference set